Ledger.Open graph →

SEC Form D · filed July 7, 2023

VistaPath Biosystems, Inc

Offering

$5.7M

Sold

$4.4M

Exemption

Rule 506(b)

Industry

Other Technology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Benjamin Burley · Cambridge, MAExec · Director Timothy Spong · Cambridge, MAExec · Director Laura Benjamin · Boston, MAExec · Director Nathan Dingler · LOS ALTOS, CAExec · Director Ian Morell · KIRKLAND, WAExec · Director Fred Rea · KIRKLAND, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗